Recon Therapeutics

Recon Therapeutics

Biotechnology

About us

Recon Therapeutics has developed The LyoKit Disposable Reconstitution System, a new patent-pending drug delivery technology that simplifies patient self-administration of biologic drugs. The LyoKit System is novel because it does not reinvent the syringe; instead, it couples a standard 3mL syringe with an external pressurized water chamber, resulting in a simple one-step reconstitution process. Please visit: www.recontherapeutics.com for more information.

Website
http://www.recontherapeutics.com
Industry
Biotechnology
Company size
2-10 employees
Type
Privately Held
Founded
2014

Employees at Recon Therapeutics

Similar pages

Browse jobs

Funding

Recon Therapeutics 1 total round

Last Round

Grant

US$ 50.0K

See more info on crunchbase